C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2742512
The present invention relates to a method for evaluating patients to help optimizing the treatment of chronic myeloid leukemia (CML) in a human patient population. Specifically, present invention relates to SHP1 and/or SHP2 as a biomarker for CML patients.
La présente invention porte sur un procédé permettant dévaluer des patients afin de mieux optimiser le traitement d'une leucémie myéloïde chronique (CML) dans une population de patients humains. Spécifiquement, la présente invention porte sur SHP1 et/ou SHP2 en tant que biomarqueur à utiliser chez des patients CML.
Esposito Nicola
Izzo Barbara
Kalebic Thea
Pane Fabrizio
Quarantelli Fabrizio
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Method for optimizing the treatment of chronic myeloid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for optimizing the treatment of chronic myeloid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for optimizing the treatment of chronic myeloid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1343894